Search for Clinical Trial Results
Carcinoid Syndrome - 50 Studies Found
Status | Study |
Completed |
Study Name: Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors Condition:
Date: 2003-03-06 Interventions: |
Completed |
Study Name: Gastrointestinal Motility in Patients With Neuroendocrine Tumors Condition: Neuroendocrine Tumor Date: 2008-11-11 Interventions: Device: Magnetic Tracking System (MTS) and radio-opaque markers MTS: A small magnetic pill (6x15mm) is s |
Completed |
Study Name: Oral Glucose Tolerance Testing (OGTT) on Patients Taking Somatostatin Analogs Condition: Acromegaly Date: 2011-06-09 Interventions: Other: Oral Glucose Tolerance Test (OGTT) An OGTT is a test that lowers growth hormone in the body to ve |
Completed |
Study Name: Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors Condition:
Date: 2008-01-25 Interventions:
|
Completed |
Study Name: AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors Condition:
|
Terminated |
Study Name: Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome Condition: Malignant Carcinoid Syndrome Date: 2004-09-22 Interventions:
|
Withdrawn |
Study Name: Study of Panitumumab in the Treatment of Carcinoid Syndrome Condition: Carcinoid Syndrome Date: 2010-07-28 Interventions: Drug: Panitumumab Panitumumab will be given by intravenous infusion at a dose of 9 mg/kg on day 1 of stu |
Completed |
Study Name: Study of LX1606 in Subjects With Symptomatic Carcinoid Syndrome Condition: Symptoms of Carcinoid Syndrome Date: 2010-04-12 Interventions:
|
Completed |
Study Name: Effects of Serotonin Excess on Bone in Carcinoid Syndrome Condition: Carcinoid Syndrome Date: 2011-08-26 |
Completed |
Study Name: Telotristat Etiprate for Carcinoid Syndrome Therapy Condition: Carcinoid Syndrome Date: 2014-02-12 Interventions:
|